These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 18191308

  • 21. Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.
    Johnson TR, Rothenberg ME, Graham BS.
    J Leukoc Biol; 2008 Sep; 84(3):748-59. PubMed ID: 18519743
    [Abstract] [Full Text] [Related]

  • 22. IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.
    Dodd JS, Lum E, Goulding J, Muir R, Van Snick J, Openshaw PJ.
    J Immunol; 2009 Dec 01; 183(11):7006-13. PubMed ID: 19915054
    [Abstract] [Full Text] [Related]

  • 23. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
    Antonis AF, van der Most RG, Suezer Y, Stockhofe-Zurwieden N, Daus F, Sutter G, Schrijver RS.
    Vaccine; 2007 Jun 15; 25(25):4818-27. PubMed ID: 17499893
    [Abstract] [Full Text] [Related]

  • 24. Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV.
    Kruijsen D, Schijf MA, Lukens MV, van Uden NO, Kimpen JL, Coenjaerts FE, van Bleek GM.
    Vaccine; 2011 Mar 24; 29(15):2730-41. PubMed ID: 21316502
    [Abstract] [Full Text] [Related]

  • 25. Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.
    Kim S, Jang JE, Yu JR, Chang J.
    Vaccine; 2010 May 14; 28(22):3801-8. PubMed ID: 20362203
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
    O'Hagan DT, Singh M, Dong C, Ugozzoli M, Berger K, Glazer E, Selby M, Wininger M, Ng P, Crawford K, Paliard X, Coates S, Houghton M.
    Vaccine; 2004 Dec 16; 23(5):672-80. PubMed ID: 15542189
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection.
    Antonis AF, Claassen EA, Hensen EJ, de Groot RJ, de Groot-Mijnes JD, Schrijver RS, van der Most RG.
    Vaccine; 2006 Mar 06; 24(10):1551-61. PubMed ID: 16310293
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.
    Elliott MB, Pryharski KS, Yu Q, Boutilier LA, Campeol N, Melville K, Laughlin TS, Gupta CK, Lerch RA, Randolph VB, LaPierre NA, Dack KM, Hancock GE.
    J Virol; 2004 Aug 06; 78(16):8446-54. PubMed ID: 15280453
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Hwang HS, Lee YT, Kim KH, Park S, Kwon YM, Lee Y, Ko EJ, Jung YJ, Lee JS, Kim YJ, Lee YN, Kim MC, Cho M, Kang SM.
    Virology; 2016 Jul 06; 494():215-24. PubMed ID: 27123586
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.
    Olszewska W, Suezer Y, Sutter G, Openshaw PJ.
    Vaccine; 2004 Nov 25; 23(2):215-21. PubMed ID: 15531040
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.